サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1522246

脂質調整剤の世界市場レポート 2024年

Lipid Regulators Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
脂質調整剤の世界市場レポート 2024年
出版日: 2024年07月29日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

脂質調整剤市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR7％で95億5,000万米ドルに成長します。予測期間の成長は、心血管疾患の有病率の増加、加齢に伴うアテローム性動脈硬化症の罹患率の上昇、肥満率の増加、メタボリックシンドロームの有病率の増加、個別化医療への注目の高まりに起因すると考えられます。予測期間中に予想される主な動向には、医薬品開発の進歩、デジタルヘルスソリューションの統合、価値に基づく価格設定モデルの採用、市販薬の需要増加、患者中心の投薬アプローチの強化の重視などがあります。

虚血性心疾患の罹患率の増加は、当面、脂質調整剤市場の拡大を促進すると予想されます。虚血性心疾患（IHD）は冠動脈疾患（CAD）としても知られ、冠動脈の狭窄や閉塞により心筋への血流が減少します。虚血性心疾患の有病率上昇の要因としては、不健康な食生活、喫煙、肥満、高血圧、糖尿病などが挙げられます。脂質調整剤は、LDLコレステロールを低下させ、HDLコレステロールを上昇させ、動脈プラークを安定化させ、炎症を抑え、内皮機能を強化することにより、虚血性心疾患のリスクと重症度を軽減し、虚血性心疾患の管理に重要な役割を果たします。例えば、2023年12月にオーストラリア保健福祉研究所（AIHW）が発表したデータによると、2020年から2021年の間に、虚血性心疾患に起因する入院が160,000件発生し、2021年だけで17,300人が死亡しました。その結果、虚血性心疾患の有病率の増加が、脂質調整剤市場拡大の主要因となっています。

脂質調整剤市場の新興国開拓企業は、心臓病患者の低比重リポ蛋白（LDL）コレステロール値の高値に対処するため、先進的な経口脂質低下薬の開発に積極的に取り組んでいます。これらの経口薬は、高コレステロールの原因となる遺伝的異常を持つ患者や心臓病と診断された患者を対象としています。例えば、2022年5月、インドの専門ジェネリック医薬品会社であるサン・ファーマシューティカル・インダストリーズ社は、心臓病患者の高LDLコレステロール値に対する画期的な治療を提供するためにデザインされた経口薬であるベンペド酸ブリロをインドで発売しました。ベンペド酸は、コレステロール産生に関与する酵素であるATPクエン酸リアーゼを阻害し、肝臓でのコレステロール合成を制御するAMP活性化プロテインキナーゼ（AMPK）を活性化することにより、二重の作用機序を発揮します。1日1回の経口投与により、他のコレステロール低下薬と比較して患者の利便性が向上します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の脂質調整剤市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の脂質調整剤市場の実績：規模と成長、2018年～2023年
  • 世界の脂質調整剤市場の予測：規模と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の脂質調整剤市場：タイプ別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 脂質調整剤
  • 麻薬性鎮痛剤
  • アンジオテンシン変換酵素（ACE）阻害剤
  • 呼吸器系薬剤
  • 利尿剤
  • カルシウム拮抗薬
  • ホルモン避妊薬
  • その他のタイプ
  • 世界の脂質調整剤市場：適応症別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 高コレステロール血症
  • 高トリグリセリド血症
  • 冠動脈疾患
  • その他の適応症
  • 世界の脂質調整剤市場：投与経路別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 経口
  • 注射
  • 世界の脂質調整剤市場：用途別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 医薬品
  • ワクチンと薬
  • 科学調査
  • 栄養とサプリメント
  • 飲食品
  • その他の用途

第7章 地域別・国別分析

  • 世界の脂質調整剤市場：地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 世界の脂質調整剤市場：国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 脂質調整剤市場：競合情勢
  • 脂質調整剤市場：企業プロファイル
    • Pfizer Inc.
    • AbbVie Inc.
    • Bayer AG
    • Sanofi SA
    • AstraZeneca plc

第31章 その他の大手企業と革新的企業

  • Bristol-Myers Squibb Company
  • Abbott Laboratories
  • Novartis AG
  • Amgen Inc.
  • Merck KGaA
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals Inc.
  • Astellas Pharma Inc.
  • Daiichi Sankyo Company Limited
  • Hetero Drugs Limited
  • Dr. Reddy's Laboratories Ltd.
  • Biocon Ltd.
  • Alnylam Pharmaceuticals Inc.
  • Amarin Corporation plc
  • Arrowhead Pharmaceuticals Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18399

Lipid regulators, also referred to as lipid-lowering drugs or hypolipidemic agents, are medications utilized to regulate blood lipid levels, specifically cholesterol and triglycerides. These drugs play a crucial role in minimizing the risk of cardiovascular disease, and they also possess anti-inflammatory properties that aid in stabilizing existing plaques and reducing the likelihood of plaque rupture and associated cardiovascular events.

The main types of lipid regulators include narcotic analgesics, angiotensin-converting enzyme (ACE) inhibitors, respiratory agents, diuretics, calcium antagonists, hormonal contraceptives, and others. Lipid regulators are medications designed to manage and control lipid levels in the body, including cholesterol and triglycerides. They are employed in treating various conditions such as hypercholesterolemia, hypertriglyceridemia, coronary artery disease, among others. These medications can be administered orally or via injection, and they find applications in pharmaceuticals, vaccines and drugs, scientific research, nutrition and supplements, food and beverages, and other sectors.

The lipid regulator market research report is one of a series of new reports from The Business Research Company that provides lipid regulator market statistics, including the lipid regulator industry global market size, regional shares, competitors with lipid regulator market share, detailed lipid regulator market segments, market trends, and opportunities, and any further data you may need to thrive in the lipid regulator industry. These lipid regulator market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lipid regulators market size has grown strongly in recent years. It will grow from $6.83 billion in 2023 to $7.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth during the historic period can be attributed to the increased prevalence of lifestyle diseases, the growth in the aging population, increased awareness of lipid regulators, rising healthcare expenditure, and an increased focus on healthcare prevention.

The lipid regulators market size is expected to see strong growth in the next few years. It will grow to $9.55 billion in 2028 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, the rising incidence of atherosclerosis with aging, increasing obesity rates, the growing prevalence of metabolic syndrome, and a growing focus on personalized medicine. Major trends expected during the forecast period include advancements in drug development, the integration of digital health solutions, adoption of value-based pricing models, increased demand for over-the-counter medications, and an emphasis on enhancing patient-centered medication approaches.

The increasing incidence of ischemic heart disease is anticipated to drive the expansion of the lipid regulator market in the foreseeable future. Ischemic heart disease (IHD), also known as coronary artery disease (CAD), involves the narrowing or blockage of coronary arteries, leading to reduced blood flow to the heart muscle. Factors contributing to the rising prevalence of ischemic heart disease include unhealthy diets, smoking, obesity, hypertension, and diabetes. Lipid regulators play a crucial role in managing ischemic heart disease by lowering LDL cholesterol, elevating HDL cholesterol, stabilizing arterial plaques, reducing inflammation, and enhancing endothelial function, thus mitigating the risk and severity of ischemic events. For instance, data from the Australian Institute of Health and Welfare (AIHW) in December 2023 revealed that between 2020 and 2021, there were 160,000 hospitalizations attributed to ischemic heart disease, resulting in 17,300 deaths in 2021 alone. Consequently, the growing prevalence of ischemic heart disease is a key driver behind the expansion of the lipid regulator market.

Leading companies in the lipid regulator market are actively developing advanced oral lipid-lowering medications to address high low-density lipoprotein (LDL) cholesterol levels in patients with heart conditions. These oral medications are targeted at individuals with inherited genetic abnormalities causing high cholesterol or those diagnosed with heart disease. For example, in May 2022, Sun Pharmaceutical Industries Limited, a specialty generic pharmaceutical company based in India, introduced Bempedoic Acid Brillo in India, an oral medication designed to provide innovative therapy for high LDL cholesterol levels in cardiac patients. Bempedoic acid exerts a dual mode of action by inhibiting ATP citrate lyase, an enzyme involved in cholesterol production, and activating AMP-activated protein kinase (AMPK), which regulates cholesterol synthesis in the liver. Its once-daily oral administration offers enhanced convenience for patients compared to certain other cholesterol-lowering medications.

In April 2023, Luye Pharma Group, a pharmaceutical company based in China, entered into a partnership with Duopharma Marketing Sdn Bhd with the objective of leveraging Duopharma Biotech's cardiovascular expertise and Luye Pharma's advanced technology to market and distribute a traditional Chinese medicine utilizing innovative fermentation techniques. This medicine harnesses unique red yeast rice to effectively manage cholesterol levels. Duopharma Marketing Sdn Bhd, a subsidiary of Duopharma Biotech Berhad (Duopharma Biotech), specializes in the manufacture of lipid regulators and cholesterol-lowering agents in Malaysia.

Major companies operating in the lipid regulators market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Limited, Dr. Reddy's Laboratories Ltd., Biocon Ltd., Alnylam Pharmaceuticals Inc., Amarin Corporation plc, Arrowhead Pharmaceuticals Inc., Kowa Pharmaceuticals America Inc. , Esperion Therapeutics Inc., Bentley Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Andrx Corporation

North America was the largest region in the lipid regulators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lipid regulators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lipid regulators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The lipid regulators market consists of sales of ezetimibe, bile acid sequestrants, fibrates, and cholesterol absorption inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lipid Regulators Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lipid regulators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lipid regulators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lipid regulators market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Lipid Regulators; Narcotic Analgesics; Angiotensin Converting Enzyme (ACE) Inhibitors; Respiratory Agents; Diuretics; Calcium Antagonists; Hormonal Contraceptives; Other Types
  • 2) By Indication: Hypercholesterolemia; Hypertriglyceridemia; Coronary Artery Disease; Other Indications
  • 3) By Administration: Oral; Injectable
  • 4) By Application: Pharmaceuticals; Vaccines And Drugs; Scientific Research; Nutrition And Supplements; Food And Beverages; Other Applications
  • Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; AstraZeneca plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lipid Regulators Market Characteristics

3. Lipid Regulators Market Trends And Strategies

4. Lipid Regulators Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Lipid Regulators Market Size and Growth

  • 5.1. Global Lipid Regulators Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Lipid Regulators Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Lipid Regulators Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lipid Regulators Market Segmentation

  • 6.1. Global Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lipid Regulators
  • Narcotic Analgesics
  • Angiotensin Converting Enzyme (ACE) Inhibitors
  • Respiratory Agents
  • Diuretics
  • Calcium Antagonists
  • Hormonal Contraceptives
  • Other Types
  • 6.2. Global Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hypercholesterolemia
  • Hypertriglyceridemia
  • Coronary Artery Disease
  • Other Indications
  • 6.3. Global Lipid Regulators Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Injectable
  • 6.4. Global Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceuticals
  • Vaccines And Drugs
  • Scientific Research
  • Nutrition And Supplements
  • Food And Beverages
  • Other Applications

7. Lipid Regulators Market Regional And Country Analysis

  • 7.1. Global Lipid Regulators Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Lipid Regulators Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lipid Regulators Market

  • 8.1. Asia-Pacific Lipid Regulators Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lipid Regulators Market

  • 9.1. China Lipid Regulators Market Overview
  • 9.2. China Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lipid Regulators Market

  • 10.1. India Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lipid Regulators Market

  • 11.1. Japan Lipid Regulators Market Overview
  • 11.2. Japan Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lipid Regulators Market

  • 12.1. Australia Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lipid Regulators Market

  • 13.1. Indonesia Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lipid Regulators Market

  • 14.1. South Korea Lipid Regulators Market Overview
  • 14.2. South Korea Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lipid Regulators Market

  • 15.1. Western Europe Lipid Regulators Market Overview
  • 15.2. Western Europe Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lipid Regulators Market

  • 16.1. UK Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lipid Regulators Market

  • 17.1. Germany Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lipid Regulators Market

  • 18.1. France Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lipid Regulators Market

  • 19.1. Italy Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lipid Regulators Market

  • 20.1. Spain Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lipid Regulators Market

  • 21.1. Eastern Europe Lipid Regulators Market Overview
  • 21.2. Eastern Europe Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lipid Regulators Market

  • 22.1. Russia Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lipid Regulators Market

  • 23.1. North America Lipid Regulators Market Overview
  • 23.2. North America Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lipid Regulators Market

  • 24.1. USA Lipid Regulators Market Overview
  • 24.2. USA Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lipid Regulators Market

  • 25.1. Canada Lipid Regulators Market Overview
  • 25.2. Canada Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lipid Regulators Market

  • 26.1. South America Lipid Regulators Market Overview
  • 26.2. South America Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lipid Regulators Market

  • 27.1. Brazil Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lipid Regulators Market

  • 28.1. Middle East Lipid Regulators Market Overview
  • 28.2. Middle East Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lipid Regulators Market

  • 29.1. Africa Lipid Regulators Market Overview
  • 29.2. Africa Lipid Regulators Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Lipid Regulators Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Lipid Regulators Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lipid Regulators Market Competitive Landscape And Company Profiles

  • 30.1. Lipid Regulators Market Competitive Landscape
  • 30.2. Lipid Regulators Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. AbbVie Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi SA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AstraZeneca plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Lipid Regulators Market Other Major And Innovative Companies

  • 31.1. Bristol-Myers Squibb Company
  • 31.2. Abbott Laboratories
  • 31.3. Novartis AG
  • 31.4. Amgen Inc.
  • 31.5. Merck KGaA
  • 31.6. Teva Pharmaceutical Industries Ltd.
  • 31.7. Regeneron Pharmaceuticals Inc.
  • 31.8. Astellas Pharma Inc.
  • 31.9. Daiichi Sankyo Company Limited
  • 31.10. Hetero Drugs Limited
  • 31.11. Dr. Reddy's Laboratories Ltd.
  • 31.12. Biocon Ltd.
  • 31.13. Alnylam Pharmaceuticals Inc.
  • 31.14. Amarin Corporation plc
  • 31.15. Arrowhead Pharmaceuticals Inc.

32. Global Lipid Regulators Market Competitive Benchmarking

33. Global Lipid Regulators Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lipid Regulators Market

35. Lipid Regulators Market Future Outlook and Potential Analysis

  • 35.1 Lipid Regulators Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Lipid Regulators Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Lipid Regulators Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer